Page last updated: 2024-10-20

trimethyloxamine and Autoimmune Diabetes

trimethyloxamine has been researched along with Autoimmune Diabetes in 1 studies

trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.

Research Excerpts

ExcerptRelevanceReference
"In individuals with type 1 diabetes, higher concentrations of plasma TMAO were associated with mortality, CVD events, and poor renal outcome, independent of conventional risk factors."1.51Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes. ( Ahluwalia, TS; Hansen, TW; Hazen, SL; Jorsal, A; Parving, HH; Pedersen, O; Rossing, P; Tarnow, L; Theilade, S; Tofte, N; Wang, Z; Winther, SA; Øllgaard, JC, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winther, SA1
Øllgaard, JC1
Tofte, N1
Tarnow, L1
Wang, Z1
Ahluwalia, TS1
Jorsal, A1
Theilade, S1
Parving, HH1
Hansen, TW1
Hazen, SL1
Pedersen, O1
Rossing, P1

Other Studies

1 other study available for trimethyloxamine and Autoimmune Diabetes

ArticleYear
Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Diabetes care, 2019, Volume: 42, Issue:8

    Topics: Aged; Biomarkers; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Diabetic Nephropathies; Fema

2019